NCT00407433View on ClinicalTrials.gov

Clinical Studies of Gemcitabine-Oxaliplatin

PHASE2CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

Not specified

Conditions
MedulloblastomaCentral Nervous System TumorsNeuroblastomaOsteosarcoma
Interventions
DRUG

Gemcitabine (Gemzar®), Oxaliplatin (Eloxatin®)

Trial Locations (1)

94800

Institut Gustave Roussy, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER

NCT00407433 - Clinical Studies of Gemcitabine-Oxaliplatin | Biotech Hunter | Biotech Hunter